Arylimidamide DB766, a Potential Chemotherapeutic Candidate for Chagas' Disease Treatment

Chagas' disease, a neglected tropical illness for which current therapy is unsatisfactory, is caused by the intracellular parasite Trypanosoma cruzi. The goal of this work is to investigate the in vitro and in vivo effects of the arylimidamide (AIA) DB766 against T. cruzi. This arylimidamide ex...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Batista, Denise da Gama Jaén, Batista, Marcos Meuser, Oliveira, Gabriel Melo de, Amaral, Patrícia Borges do, Lannes-Vieira, Joseli, Britto, Constança Carvalho, Junqueira, Angela, Lima, Marli Maria, Romanha, Alvaro José, Sales Junior, Policarpo Ademar, Stephens, Chad E., Boykin, David W., Soeiro, Maria de Nazaré Correia
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology (ASM) 2010
Témata:
Experimental Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2897275/
https://ncbi.nlm.nih.gov/pubmed/20457822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01617-09
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky